CS
ETNB

Credit Suisse’s 89bio ETNB Stock Holding History

Credit Suisse’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$700K Buy
60,103
+3,268
+6% +$36.2K ﹤0.01% 2477
2023
Q4 		$635K Buy
56,835
+6,874
+14% +$63.2K ﹤0.01% 2610
2023
Q3 		$771K Sell
49,961
-19,057
-28% -$320K ﹤0.01% 2451
2023
Q2 		$1.31M Buy
+69,018
New +$1.21M ﹤0.01% 2204
2022
Q3 		– Sell
-5
Closed – – 4103
2022
Q2 		$0 Buy
+5
New +$15 ﹤0.01% 4034

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Credit Suisse's ETNB Position: Q1 2024 in Review

Credit Suisse increased its 89bio (ETNB) stake by 5.7% in Q1 2024, buying an estimated $36.2K and bringing the position to 60,103 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.

Credit Suisse first reported a position in ETNB in Q2 2022 and has held it in 5 quarters since. The position peaked at $1.31M in Q2 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

  • Credit Suisse held 60,103 shares of 89bio worth $700K as of Q1 2024.
  • Credit Suisse bought 3,268 89bio shares in Q1 2024, an estimated $36.2K.
  • 89bio made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2477 holding.
  • Credit Suisse first reported a position in 89bio in Q2 2022 and has held it in 5 quarters since.
  • Credit Suisse's 89bio position peaked at $1.31M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.